Paranoid Android: FDA Advisory Committee Continues to Evaluate AI Mental Health Tools

Start
Key Takeaways – FDA oversight of AI mental health tools is accelerating. The Digital Health Advisory Committee’s (“DHAC’s”) November 2025 meeting highlights FDA’s increased attention to digital health technologies such as mental health chatbots which utilize generative AI….
By: Arnall Golden Gregory LLP
Previous Story

6 Things Healthcare Leaders Need to Know About HHS’s New AI RFI

Next Story

Client Alert: The US Office of Space Commerce Seeks Industry Feedback on a Potential New Regulatory Authorization Regime for “Novel” Commercial Space Activities